What is the recommended dose of Pepcid (Famotidine) for treating allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pepcid (Famotidine) Dosing for Allergic Reactions

For acute allergic reactions and anaphylaxis, famotidine is dosed at 1-2 mg/kg (maximum 75-150 mg) intravenously or orally in the hospital setting, and is NOT recommended as monotherapy but only as adjunctive treatment to epinephrine. 1

Context and Role in Allergy Treatment

Famotidine (Pepcid) is an H2-antihistamine that serves as second-line adjunctive therapy only in allergic reactions—it should never be used alone or as a substitute for epinephrine in anaphylaxis. 1 The combination of H1-antihistamines (like diphenhydramine) with H2-antihistamines (like famotidine or ranitidine) is superior to H1-antihistamines alone, but both have a much slower onset of action than epinephrine. 1

Specific Dosing Recommendations

In Hospital-Based Settings (Acute Anaphylaxis)

For children:

  • 1-2 mg/kg per dose 1
  • Maximum dose: 75-150 mg (oral or IV) 1

For adults:

  • Maximum dose: 75-150 mg (oral or IV) 1

The guidelines specifically mention ranitidine dosing (another H2-blocker) as 50 mg in adults and 12.5-50 mg (1 mg/kg) in children, which can be diluted and given IV over 5 minutes. 1 While famotidine is not explicitly dosed in the older anaphylaxis guidelines, the NIAID food allergy guidelines provide the weight-based dosing above. 1

At Discharge (Post-Anaphylaxis)

H2-antihistamine (ranitidine or famotidine):

  • Twice daily for 2-3 days 1
  • This is given alongside H1-antihistamines and corticosteroids as part of post-discharge adjunctive therapy 1

Critical Clinical Caveats

Never use famotidine as first-line treatment. Epinephrine is the only first-line treatment for anaphylaxis—intramuscular epinephrine 0.01 mg/kg (maximum 0.5 mg) must be given immediately. 1 Famotidine and other H2-blockers are added only after epinephrine administration.

Onset of action is slow. H2-antihistamines take significantly longer to work than epinephrine, which is why they cannot be relied upon for acute life-threatening reactions. 1

Prophylactic use in allergic patients: Research suggests that combined H1 and H2-receptor antagonist premedication (chlorpheniramine plus famotidine) can prevent histamine release in allergic patients undergoing procedures, though this is not standard practice for routine allergic reactions. 2

Practical Algorithm for Use

  1. Acute anaphylaxis: Give IM epinephrine first (0.01 mg/kg, max 0.5 mg) 1
  2. Add famotidine as adjunctive therapy: 1-2 mg/kg IV/oral (max 75-150 mg) 1
  3. Continue at discharge: Famotidine twice daily for 2-3 days 1
  4. Monitor: Famotidine is well-tolerated with minimal drug interactions and primarily renal elimination 3

Important note: While famotidine itself can rarely cause anaphylactic reactions, this is exceedingly uncommon. 4 Cross-reactivity between different H2-blockers has not been demonstrated, so alternative H2-blockers can be used if famotidine causes a reaction. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

H1- and H2-receptor antagonists prevent histamine release in allergic patients after the administration of midazolam-ketamine. A randomized controlled study.

Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1999

Research

Clinical pharmacology of famotidine: a summary.

Journal of clinical gastroenterology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.